Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Shares of Sammaan Capital are banned from F&O trading on Wednesday 04 March 2026.
Stocks to Watch:
Oil sensitive stocks will continue to remain as tensions in West Asia persist.
Adani Ports & Special Economic Zone (APSEZ) handled 42.5 MT in February 2026, registering the growth of 16% YoY. Logistics rail volume stood at 52,101 TEUs in February 2026, up 3% YoY.
Natco Pharma along with its partner Breckenridge Pharmaceutical, Inc announces launch of Pomalidomide Capsules. The said drug is indicated for the treatment of adult patients with multiple myeloma who have received at least two prior therapies
Gland Pharma’s chief executive officer(CEO), Shyamakant Giri, has resigned from the position with effect from 30 April 2026.
Juniper Hotels has received letter of award (LoA) from Delhi Development Authority (DDA) to develop 5 star hotel property on licensed land parcel in Dwarka, New Delhi
Allied Blenders and Distillers' board approved to acquire upto 50% stake in Kion Blenders Industries for total consideration of Rs 45 crore.
JSW Cement has been declared as the preferred bidder for the mining lease of the Sikilangso Limestone Block (Part A & Part B) located in Umrangso, Dima Hasao District, Assam.
The drug is also approved for AIDS-related Kaposi sarcoma after failure of highly active antiretroviral therapy (HAART), as well as for HIV-negative adult patients with Kaposi sarcoma. The product is available in 1 mg, 2 mg, 3 mg, and 4 mg strengths and is primarily distributed through specialty pharmacies and clinics.
NATCO said based on information made available by the U.S. Food and Drug Administration (FDA), it believes that it has 180 days of shared exclusivity. Pomalidomide Capsules 1 mg, 2 mg, 3 mg, and 4 mg had estimated sales of $3.2 billion in the U.S. for the 12 months ending September 2025, the company said, citing industry sales data.
Rajeev Nannapaneni, vice chairman and chief executive officer of NATCO Pharma, said, “We are pleased to launch Pomalidomide Capsules in the U.S.; this further strengthens our oncology and specialty portfolio in the U.S. The launch highlights our commitment to our mission of making specialty medicines accessible to all the patients worldwide. We look forward to bringing more such complex and specialty products to the market in the coming years.”
NATCO Pharma, headquartered in Hyderabad, India, develops, manufactures, and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients, and crop protection products.
The company’s consolidated net profit jumped 13.9% to Rs 151.50 crore on a 36.3% increase in revenue from operations to Rs 647.30 crore in Q3 FY26 over Q3 FY25.
Fine Organic Industries Ltd, Natco Pharma Ltd, Apollo Micro Systems Ltd and Jammu and Kashmir Bank Ltd are among the other gainers in the BSE's 'A' group today, 24 February 2026.
Thangamayil Jewellery Ltd spiked 4.92% to Rs 3771.5 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 12753 shares were traded on the counter so far as against the average daily volumes of 9643 shares in the past one month.
Fine Organic Industries Ltd soared 4.66% to Rs 4862.5. The stock was the second biggest gainer in 'A' group. On the BSE, 7484 shares were traded on the counter so far as against the average daily volumes of 941 shares in the past one month.
Natco Pharma Ltd surged 4.63% to Rs 934.55. The stock was the third biggest gainer in 'A' group. On the BSE, 6.43 lakh shares were traded on the counter so far as against the average daily volumes of 1.53 lakh shares in the past one month.
Apollo Micro Systems Ltd added 4.34% to Rs 240.55. The stock was the fourth biggest gainer in 'A' group. On the BSE, 1.86 lakh shares were traded on the counter so far as against the average daily volumes of 1.59 lakh shares in the past one month.
Jammu and Kashmir Bank Ltd jumped 4.18% to Rs 110.9. The stock was the fifth biggest gainer in 'A' group. On the BSE, 12.05 lakh shares were traded on the counter so far as against the average daily volumes of 2.05 lakh shares in the past one month.
Natco Pharma Ltd, Cartrade Tech Ltd, KFin Technologies Ltd and Engineers India Ltd are among the other gainers in the BSE's 'A' group today, 16 February 2026.
Easy Trip Planners Ltd soared 11.95% to Rs 7.4 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 34.75 lakh shares were traded on the counter so far as against the average daily volumes of 11.75 lakh shares in the past one month.
Natco Pharma Ltd surged 8.70% to Rs 893.65. The stock was the second biggest gainer in 'A' group. On the BSE, 12.11 lakh shares were traded on the counter so far as against the average daily volumes of 40895 shares in the past one month.
Cartrade Tech Ltd spiked 7.51% to Rs 2083.45. The stock was the third biggest gainer in 'A' group. On the BSE, 41903 shares were traded on the counter so far as against the average daily volumes of 31425 shares in the past one month.
KFin Technologies Ltd spurt 6.27% to Rs 1028.8. The stock was the fourth biggest gainer in 'A' group. On the BSE, 1.04 lakh shares were traded on the counter so far as against the average daily volumes of 35506 shares in the past one month.
Engineers India Ltd added 6.07% to Rs 214.1. The stock was the fifth biggest gainer in 'A' group. On the BSE, 30.9 lakh shares were traded on the counter so far as against the average daily volumes of 4.66 lakh shares in the past one month.
J B Chemicals & Pharmaceuticals Ltd, Natco Pharma Ltd, Ambuja Cements Ltd, RHI Magnesita India Ltd are among the other stocks to see a surge in volumes on BSE today, 16 February 2026.
C.E. Info Systems Ltd notched up volume of 1.52 lakh shares by 10:46 IST on BSE, a 53.98 fold spurt over two-week average daily volume of 2820 shares. The stock slipped 5.66% to Rs.1,165.00. Volumes stood at 6144 shares in the last session.
J B Chemicals & Pharmaceuticals Ltd saw volume of 76141 shares by 10:46 IST on BSE, a 23.01 fold spurt over two-week average daily volume of 3308 shares. The stock increased 5.55% to Rs.1,997.80. Volumes stood at 3964 shares in the last session.
Natco Pharma Ltd witnessed volume of 6.56 lakh shares by 10:46 IST on BSE, a 14.9 times surge over two-week average daily volume of 44074 shares. The stock increased 11.41% to Rs.915.90. Volumes stood at 82829 shares in the last session.
Ambuja Cements Ltd recorded volume of 9.85 lakh shares by 10:46 IST on BSE, a 12.57 times surge over two-week average daily volume of 78368 shares. The stock gained 0.12% to Rs.519.90. Volumes stood at 2.05 lakh shares in the last session.
RHI Magnesita India Ltd saw volume of 56167 shares by 10:46 IST on BSE, a 9.65 fold spurt over two-week average daily volume of 5821 shares. The stock increased 7.37% to Rs.469.30. Volumes stood at 3035 shares in the last session.
Akums Drugs & Pharmaceuticals Ltd, RHI Magnesita India Ltd, Brainbees Solutions Ltd, Inox Wind Ltd are among the other stocks to see a surge in volumes on NSE today, 16 February 2026.
Natco Pharma Ltd witnessed volume of 188.67 lakh shares by 14:14 IST on NSE, a 30.19 times surge over two-week average daily volume of 6.25 lakh shares. The stock increased 9.68% to Rs.903.60. Volumes stood at 4.52 lakh shares in the last session.
Akums Drugs & Pharmaceuticals Ltd registered volume of 22.18 lakh shares by 14:14 IST on NSE, a 21.84 fold spurt over two-week average daily volume of 1.02 lakh shares. The stock rose 6.35% to Rs.480.00. Volumes stood at 70716 shares in the last session.
RHI Magnesita India Ltd registered volume of 13.51 lakh shares by 14:14 IST on NSE, a 9.47 fold spurt over two-week average daily volume of 1.43 lakh shares. The stock rose 4.88% to Rs.457.95. Volumes stood at 1.13 lakh shares in the last session.
Brainbees Solutions Ltd clocked volume of 77.54 lakh shares by 14:14 IST on NSE, a 7.68 times surge over two-week average daily volume of 10.10 lakh shares. The stock lost 10.49% to Rs.241.50. Volumes stood at 10.2 lakh shares in the last session.
Inox Wind Ltd notched up volume of 456.78 lakh shares by 14:14 IST on NSE, a 6.18 fold spurt over two-week average daily volume of 73.91 lakh shares. The stock slipped 3.03% to Rs.103.16. Volumes stood at 78.58 lakh shares in the last session.
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
Further, the Company has received the EIR (Establishment Inspection Report) from the USFDA on the classification of the above-referred inspection as Voluntary Action Indicated (VAI).